SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
xuqianlan
Lv2
190 积分
2023-07-07 加入
最近求助
最近应助
互助留言
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
15小时前
已完结
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
1天前
已完结
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
1天前
已完结
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
1天前
已完结
New advances in the diagnosis and management of hepatocellular carcinoma
1天前
已完结
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
1天前
已完结
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2天前
已完结
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
3天前
已完结
Programmed cell death and cancer
1个月前
已完结
Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma
2个月前
已完结
没有进行任何应助
感谢
1年前
点赞
1年前
感谢
1年前
感谢
1年前
点赞
1年前
感谢
1年前
感谢
1年前
帮大忙了
1年前
速度真快
1年前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论